Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development - PubMed (original) (raw)
Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development
Silvia Gregori et al. J Immunol. 2003.
Abstract
In the nonobese diabetic (NOD) mouse, pathogenic and suppressor CD4(+) T cells can be distinguished by the constitutive expression of CD25. In this study, we demonstrate that the progression of autoimmune diabetes in NOD mice reflects modifications in both T cell subsets. CD4(+)CD25(+) suppressor T cells from 8-, but not 16-wk-old NOD mice delayed the onset of diabetes transferred by 16-wk-old CD25-depleted spleen cells. These results were paralleled by the inhibition of alloantigen-induced proliferation of CD4(+)CD25(-) cells, indicating an age-dependent decrease in suppressive activity. In addition, CD4(+)CD25(-) pathogenic T cells became progressively less sensitive to immunoregulation by CD4(+)CD25(+) T cells during diabetes development. CD4(+)CD25(-) T cells showed a higher proliferation and produced more IFN-gamma, but less IL-4 and IL-10, whereas CD4(+)CD25(+) T suppressor cells produced significantly lower levels of IL-10 in 16- compared with 8-wk-old NOD mice. Consistent with these findings, a higher frequency of Th1 cells was observed in the pancreas of 16-wk-old compared with 8-wk-old NOD mice. An increased percentage of CD4(+)CD25(-) T cells expressing CD54 was present in 16-wk-old and in diabetic NOD, but not in BALB/c mice. Costimulation via CD54 increased the proliferation of CD4(+)CD25(-) T cells from 16-, but not 8-wk-old NOD mice, and blocking CD54 prevented their proliferation, consistent with the role of CD54 in diabetes development. Thus, the pathogenesis of autoimmune diabetes in NOD mice is correlated with both an enhanced pathogenicity of CD4(+)CD25(-) T cells and a decreased suppressive activity of CD4(+)CD25(+) T cells.
Similar articles
- Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C, Lee WH, Yun P, Snow P, Liu CP. Chen C, et al. J Immunol. 2003 Jul 15;171(2):733-44. doi: 10.4049/jimmunol.171.2.733. J Immunol. 2003. PMID: 12847240 - Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W, Hussain S, Mi QS, Santamaria P, Delovitch TL. Yang W, et al. J Immunol. 2004 Oct 1;173(7):4407-16. doi: 10.4049/jimmunol.173.7.4407. J Immunol. 2004. PMID: 15383571 - CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L. Chatenoud L. Novartis Found Symp. 2003;252:279-86; discussion 286-90. Novartis Found Symp. 2003. PMID: 14609225 Review. - Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.
Thornton AM. Thornton AM. Front Biosci. 2006 Jan 1;11:921-7. doi: 10.2741/1848. Front Biosci. 2006. PMID: 16146782 Review.
Cited by
- The protective effect of the intestinal microbiota in type-1 diabetes in NOD mice is limited to a time window in early life.
Fernandez Trigo N, Kalbermatter C, Yilmaz B, Ganal-Vonarburg SC. Fernandez Trigo N, et al. Front Endocrinol (Lausanne). 2024 Sep 26;15:1425235. doi: 10.3389/fendo.2024.1425235. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39391872 Free PMC article. - Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging-related diseases.
Xia T, Zhou Y, An J, Cui Z, Zhong X, Cui T, Lv B, Zhao X, Gao X. Xia T, et al. Aging Cell. 2024 Oct;23(10):e14317. doi: 10.1111/acel.14317. Epub 2024 Aug 18. Aging Cell. 2024. PMID: 39155409 Free PMC article. Review. - Rodent models for diabetes.
Rashmi P, Urmila A, Likhit A, Subhash B, Shailendra G. Rashmi P, et al. 3 Biotech. 2023 Mar;13(3):80. doi: 10.1007/s13205-023-03488-0. Epub 2023 Feb 9. 3 Biotech. 2023. PMID: 36778766 Free PMC article. Review. - β-Cell Cre Expression and Reduced Ins1 Gene Dosage Protect Mice From Type 1 Diabetes.
Skovsø S, Overby P, Memar-Zadeh J, Lee JTC, Yang JCC, Shanina I, Sidarala V, Levi-D'Ancona E, Zhu J, Soleimanpour SA, Horwitz MS, Johnson JD. Skovsø S, et al. Endocrinology. 2022 Oct 11;163(11):bqac144. doi: 10.1210/endocr/bqac144. Endocrinology. 2022. PMID: 36048448 Free PMC article. - Gut Microbiota, Leaky Gut, and Autoimmune Diseases.
Christovich A, Luo XM. Christovich A, et al. Front Immunol. 2022 Jun 27;13:946248. doi: 10.3389/fimmu.2022.946248. eCollection 2022. Front Immunol. 2022. PMID: 35833129 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials